Sound Financial Strategies Group LLC purchased a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm purchased 30,569 shares of the exchange traded fund’s stock, valued at approximately $3,644,000. SPDR S&P Biotech ETF comprises 2.3% of Sound Financial Strategies Group LLC’s investment portfolio, making the stock its 9th largest position.
Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. Axiom Investment Management LLC bought a new position in shares of SPDR S&P Biotech ETF during the 1st quarter worth about $26,000. Financial Life Planners bought a new stake in shares of SPDR S&P Biotech ETF in the first quarter valued at about $27,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter valued at about $27,000. Intesa Sanpaolo Wealth Management acquired a new stake in SPDR S&P Biotech ETF during the fourth quarter worth about $30,000. Finally, SHP Wealth Management acquired a new stake in SPDR S&P Biotech ETF during the fourth quarter worth about $31,000.
SPDR S&P Biotech ETF Stock Up 0.4%
Shares of XBI opened at $160.11 on Wednesday. SPDR S&P Biotech ETF has a 12-month low of $88.18 and a 12-month high of $165.71. The firm has a market capitalization of $10.46 billion, a price-to-earnings ratio of 11.47 and a beta of 0.83. The stock’s 50-day moving average price is $151.93 and its 200 day moving average price is $136.92.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Featured Articles
- Five stocks we like better than SPDR S&P Biotech ETF
- The AI Boom Is Turning This Cable Maker Into a Stock to Watch
- A Star Investor Just Trimmed Amazon—Here’s What It means
- Wendy’s Deal Buzz May Give Fast-Food Investors a New Reason to Look
- Home Depot Analysts See a Path to $375 and Beyond
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
